
This article discusses the retiring of Ph. Eur. and USP heavy metal assays as well as a means of updating related specifications with minimal regulatory burden.
Elisabeth Corbett is associate director, Global Regulatory Sciences, CMC, Bristol-Myers Squibb.

This article discusses the retiring of Ph. Eur. and USP heavy metal assays as well as a means of updating related specifications with minimal regulatory burden.

The authors support the retiring of Ph. Eur. and USP heavy metal assays and propose a means of updating related specifications with minimal regulatory burden.

Published: September 1st 2018 | Updated:

Published: October 3rd 2018 | Updated: